The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citation
Cited by
Items 101–200 of 634
Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells
Weigert, A., Cremer, S., Schmidt, M. V., von Knethen, A., Angioni, C., Geisslinger, G., & Brüne, B. (2010) · Blood · doi:10.1182/blood-2009-10-243444 · Cited by 87
“Especially its role in immune regulation and tumor biology attracted considerable interest.(3,4) S1P is produced by phosphorylation of sphingosine by sphingosine kinases.”
BackgroundSun, N., Shen, Y., Han, W., Shi, K., Wood, K., Fu, Y., Hao, J., Liu, Q., Sheth, K. N., Huang, D., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.012236 · Cited by 91
“Sphingosine-1-phosphate (S1P) is a ligand for 5 G-protein– coupled receptors: S1P receptors 1 to 5 (S1PR1–5) are responsible for numerous cell-intrinsic and extrinsic activities.(11,12) Fingolimod (FTY720, Glenya), an oral therapy for multiple sclerosis (MS), is a S1PR modulator that binds to S1PR1, 3, 4, and 5.”
BackgroundHost conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
Lee, P., Yamamoto, T. N., Gurusamy, D., Sukumar, M., Yu, Z., Hu‐Li, J., Kawabe, T., Gangaplara, A., Kishton, R. J., Henning, A. N., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181218 · Cited by 89
“…with inherent tumor reactivities or autologous T cells genetically modified to express tumorreactive TCRs or chimeric antigen receptors can mediate durable tumor regression in several malignancies (Rosenberg et al., 2008; Rosenberg and Restifo, 2015; June et al., 2018; June and Sadelain, 2018).”
BackgroundMast Cells and Influenza A Virus: Association with Allergic Responses and Beyond
Graham, A. C., Temple, R. M., & Obar, J. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00238 · Cited by 85
“Signaling through the S1PR2 has also been shown to regulate mast cell responses in general (31, (151) (152) (153) (154) .”
BackgroundLi, L., Wang, H., Zhang, J., Sha, Y., Wu, F., Wen, S., He, L., Sheng, L., You, Q., Shi, M., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0471-x · Cited by 80
Strutt, T. M., McKinstry, K. K., Kuang, Y., Bradley, L. M., & Swain, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205894109 · Cited by 81
Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders
Bagdanoff, J. T., Donoviel, M. S., Nouraldeen, A. M., Tarver, J., Fu, Q., Carlsen, M., Jessop, T. C., Zhang, H., Hazelwood, J., Nguyen, H. V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900278w · Cited by 78
Structure and Function of Sphingosine-1-Phosphate Lyase, a Key Enzyme of Sphingolipid Metabolism
Bourquin, F., Riezman, H., Capitani, G., & Grütter, M. G. (2010) · Structure · doi:10.1016/j.str.2010.05.011 · Cited by 88
“…ranging from Arabidopsis thaliana (Dunn et al., 2004; Pata et al., 2009; Tsegaye et al., 2007), Saccharomyces cerevisiae to Caenorhabditis elegans (Oskouian and Saba, 2004),Mus musculus (Forrest et al., 2004), and Homo sapiens (Oskeritzian et al., 2007; Rivera et al., 2008; Saba and Hla, 2004).”
BackgroundScientific Opinion on the re‐evaluation of caramel colours (E 150 a,b,c,d) as food additives
(ANS), E. P. O. F. A. A. N. S. A. T. F. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2004 · Cited by 76
Gupta, P., Mohammad, T., Dahiya, R., Roy, S., Noman, O. M., Alajmi, M. F., Hussain, A., & Hassan, M. I. (2019) · Scientific Reports · doi:10.1038/s41598-019-55199-3 · Cited by 77
Lysophospholipid receptors in vertebrate development, physiology, and pathology
Skoura, A., & Hla, T. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800047-jlr200 · Cited by 76
“whereas S1P through its receptors regulates migration and degranulation of mast cells/eosinophils, crucial events in asthma, allergic dermatitis and other allergic inflammatory diseases (57).”
BackgroundDissecting the Role of the S1P/S1PR Axis in Health and Disease
Aarthi, J. J., Darendeliler, M. A., & Pushparaj, P. N. (2011) · Journal of Dental Research · doi:10.1177/0022034510389178 · Cited by 77
“and the perinuclear region (Rivera et al., 2008).”
Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis
Andersson, A., Stubelius, A., Karlsson, M. N., Engdahl, C., Erlandsson, M. C., Grahnemo, L., Lagerquist, M. K., & Islander, U. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0548-y · Cited by 81
“Pharmacologic disruption of the S1P–S1PR1 interaction ameliorates CIA as a consequence of blocked lymphocyte egress from LNs [40].”
BackgroundInfluentialS1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion
Olesch, C., Sirait‐Fischer, E., Berkefeld, M., Fink, A. F., Susen, R. M., Ritter, B., Michels, B. E., Steinhilber, D., Greten, F. R., Savai, R., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136928 · Cited by 76
“In the circulation, S1P acts as a major chemoattractant for lymphocytes entering the circulation from peripheral and lymphoid tissues (4).”
BackgroundMatesanz-Isabel, J., Sintes, J., Llinàs, L., de Salort, J., Lázaro, A., & Engel, P. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.09.019 · Cited by 86
The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity
Martı́n, P., Gómez, M., Lamana, A., Matesanz-Marín, A., Cortés, J. R., Ramírez‐Huesca, M., Barreiro, O., López‐Romero, P., Gutiérrez‐Vázquez, C., de la Fuente, H., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.010 · Cited by 80
Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease
Nielsen, O. H., Li, Y., Johansson‐Lindbom, B., & Coskun, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.002 · Cited by 79
Sun, N., Keep, R. F., Hua, Y., & Xi, G. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0477-3 · Cited by 72
“For example, S1P regulates lymphocyte trafficking [4], glial cell activation [2, 5], vasoconstriction [6, 7], endothelial barrier function [8, 9], and neuronal death pathways [10, 11], which act as important components in many neurological conditions [1].”
Meißner, A., Miró‐Mur, F., Jiménez‐Altayó, F., Jurado, A., Vila, E., & Planas, A. M. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvw256 · Cited by 75
The Role of Cytokine Responses During Influenza Virus Pathogenesis and Potential Therapeutic Options
Teijaro, J. R. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_411 · Cited by 80
“Binding through these five receptors is known to modulate multiple cellular functions including: cell adhesion, migration, survival, proliferation, endocytosis, barrier function, and cytokine production (Rivera et al. 2008).”
BackgroundDisruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis
Ma, Y., Zhang, X., Xuan, B., Li, D., Yin, N., Ning, L., Zhou, Y., Yan, Y., Tong, T., Zhu, X., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-330009 · Cited by 78
“36 44 In our study, we observed higher S1P levels in the supernatant of the Fto knockdown IEC line MODE-K, which in turn promoted inflammatory macrophages, particularly the Mac-Saa1 subcluster.”
BackgroundEmerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis
Huang, W., Nagahashi, M., Terracina, K. P., & Takabe, K. (2013) · Biomolecules · doi:10.3390/biom3030408 · Cited by 75
“The combination and cell-type-specific expression of different S1PRs determines a broad range of biological functions mediated by S1P [129,149,150].”
BackgroundBurow, P., Klapperstück, M., & Markwárdt, F. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1561-8 · Cited by 72
Lyase to live by: Sphingosine phosphate lyase as a therapeutic target
Kumar, A., & Saba, J. D. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903039722 · Cited by 75
“Activation of S1P receptors stimulates downstream signaling pathways, including those involving MAPK, PI3K kinase, cAMP and other downstream mediators [6,7].”
BackgroundRathinasamy, A., Czeloth, N., Pabst, O., Förster, R., & Bernhardt, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000568 · Cited by 70
“widely expressed in the immune system; however, such expression occurs in a cell-type–specific pattern (18).”
BackgroundRoviezzo, F., D’Agostino, B., Brancaleone, V., Gruttola, L. D., Bucci, M., Dominicis, G. D., Orlotti, D., D’Aiuto, E., Palma, R. D., Rossi, F., et al. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0108oc · Cited by 69
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
Fudman, D. I., McConnell, R. A., Ha, C. Y., & Singh, S. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.050 · Cited by 69
Xiao, L., Zhou, Y., Zhu, L., Yang, S., Huang, R. S., Shi, W., Peng, B., & Xiao, Y. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3396 · Cited by 68
“FTY720-P is originally considered as an S1PR1agonist;(73,74) however, further studies have identified that it actually acts as a functional antagonist on S1PR1.”
BackgroundInfluentialThe role of sphingosine-1-phosphate in bone remodeling and osteoporosis
Grewe, J. M., Knapstein, P., Donat, A., Jiang, S., Smit, D. J., Xie, W., & Keller, J. (2022) · Bone Research · doi:10.1038/s41413-022-00205-0 · Cited by 76
“These discrepancies might be related to the fact that local S1P-dependent signaling events within the BMU may not necessarily reflect the systemic situation, since S1P concentrations in the blood are much higher than those in other tissues, including bone.(67) Alternatively, it has been suggested that the primary effe…”
BackgroundApoptotic cells enhance sphingosine‐1‐phosphate receptor 1 dependent macrophage migration
Weichand, B., Weis, N., Weigert, A., Grossmann, N., Levkau, B., & Brüne, B. (2013) · European Journal of Immunology · doi:10.1002/eji.201343441 · Cited by 68
Mair, N., Benetti, C., Andratsch, M., Leitner, M. G., Constantin, C., Camprubí-Robles, M., Quarta, S., Biasio, W., Kuner, R., Gibbins, I. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017268 · Cited by 69
“In rheumatoid synovium S1P/S1P1 receptor signaling appears to be a key regulator of the local immune response [2,4], and increasing evidence supports a critical role of S1P in autoimmune processes in RA [23].”
S1P Is Associated with Protection in Human and Experimental Cerebral Malaria
Finney, C. A. M., Hawkes, C. A., Kain, D. C., Dhabangi, A., Musoke, C., Cserti-Gazdewich, C. M., Oravecz, T., Liles, W. C., & Kain, K. C. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00214 · Cited by 69
John, A. L. S., Ang, W. X. G., Huang, M.-N., Kunder, C. A., Chan, E., Gunn, M. D., & Abraham, S. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.07.013 · Cited by 67
“Based on this, we employed the broadly acting S1P receptor agonist, FTY720 (also known as Fingolimod), which binds multiple S1P receptors to block cellular exit from LNs (Brinkmann et al., 2002; Rivera et al., 2008).”
MethodFernández‐Pisonero, I., Dueñas, A. I., Barreiro, O., Montero, O., Sánchez‐Madrid, F., & García‐Rodríguez, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201309 · Cited by 73
“Many of the actions of S1P are mediated by the activation of receptors, initially known as endothelial differentiation genes and now designated as S1P1–5, which are high-affinity receptors coupled to G proteins (aio, aq, or a12/13) that trigger the activation of multiple signals leading to specific cell responses (4).”
BackgroundLewis, N. D., Haxhinasto, S. A., Anderson, S. M., Stefanopoulos, D. E., Fogal, S. E., Adusumalli, P., Desai, S. N., Patnaude, L. A., Lukas, S. M., Ryan, K. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201810 · Cited by 67
“A gradient of S1P is recognized by S1P receptors on immune cells, leading to their entry into circulation (2).”
BackgroundMacrophage–Bacteria Interactions—A Lipid-Centric Relationship
Teng, O., Ang, C. K. E., & Guan, X. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01836 · Cited by 69
“Expression of S1PRs determines the function of an immune cell, as they play critical roles in lymphocyte trafficking, differentiation and triggering of inflammatory responses (106).”
BackgroundS1PR3 Mediates Itch and Pain via Distinct TRP Channel-Dependent Pathways
Hill, R. Z., Morita, T., Brem, R. B., & Bautista, D. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1266-18.2018 · Cited by 72
“…et al., 2004; Sugita et al., 2010), and scleroderma (Castelino and Varga, 2014), as well as neuropathic pain (Patti et al., 2012; Janes et al., 2014) and other inflammatory diseases (Rivera et al., 2008; Chiba et al., 2010; Tränkner et al., 2014; Donoviel et al., 2015; Roviezzo et al., 2015).”
BackgroundJena, P. K., Sheng, L., McNeil, K. D., Chau, T., Yu, S., Kiuru, M. H., Fung, M. A., Hwang, S. T., & Wan, Y. Y. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.05.007 · Cited by 69
“Additionally, higher levels of circulating S1P promotes Th2 response and increase the number of Th2 and Th17 cells as well as the ratio of M2 to M1 macrophages [22].”
BackgroundOskeritzian, C. A., Hait, N. C., Wedman, P., Chumanevich, A. P., Kolawole, E. M., Price, M. M., Falanga, Y. T., Harikumar, K. B., Ryan, J. J., Milstien, S., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.044 · Cited by 74
Aurelio, L., Scullino, C. V., Pitman, M. R., Sexton, A. E., Oliver, V., Davies, L. T., Rebello, R. J., Furic, L., Creek, D. J., Pitson, S. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01439 · Cited by 67
Thomas, K., Sehr, T., Proschmann, U., Rodriguez-Leal, F. A., Haase, R., & Ziemssen, T. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0817-6 · Cited by 66
“Previous reports have shown a similar pattern of decrease of pro-inflammatory cytokines by fingolimod in murine bone marrow-derived DCs and induction of anti-inflammatory macrophages [14, 15, 19, 24].”
BackgroundResultInfluentialThe Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis
Rohrhofer, J., Zwirzitz, B., Selberherr, E., & Untersmayr, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635704 · Cited by 71
Ratajczak, M. Z., Suszyńska, M., Borkowska, S., Ratajczak, J., & Schneider, G. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.851671 · Cited by 69
“First, as S1P2 counteracts the biological effects of S1P1 and S1P3 receptors and mediates some inhibitory effects on the migration of HSPCs [15], we envision that by blocking S1P2 with a small-molecule antagonist, e.”
BackgroundCurrent Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
Trakaki, A., & Marsche, G. (2021) · Biomedicines · doi:10.3390/biomedicines9060587 · Cited by 76
Ma, S., Sandhoff, R., Luo, X., Shang, F., Shi, Q., Li, Z., Wu, J., Ming, Y., Schwarz, F., Madi, A., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adg8817 · Cited by 70
Differential responses of human microglia and blood-derived myeloid cells to FTY720
Durafourt, B. A., Lambert, C., Johnson, T., Blain, M., Bar‐Or, A., & Antel, J. P. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.006 · Cited by 67
“Signaling through the S1P1 receptor was shown to induce Rac1 GTPase associated-ERK1/2 phosphorylation in receptor transfected cell lines and some primary cells such as astrocytes and endothelial cells (Osinde et al., 2007; Rivera et al., 2008; Lee et al., 2001; Mullershausen et al., 2009).”
BackgroundECM1 controls TH2 cell egress from lymph nodes through re-expression of S1P1
Li, Z., Zhang, Y., Liu, Z., Wu, X., Zheng, Y., Tao, Z., Mao, K., Wang, J., Lin, G., Tian, L. H., et al. (2011) · Nature Immunology · doi:10.1038/ni.1983 · Cited by 65
“Recent studies indicate that emigration of T cells from thymus and secondary lymphoid organs is also regulated by S1P receptor”
BackgroundPotì, F., Gualtieri, F., Sacchi, S., Weißen-Plenz, G., Varga, G., Brodde, M. F., Weber, C., Simoni, M., & Nofer, J. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301347 · Cited by 65
Sphingosine‐1‐Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation
Mahajan, S. G., Böhm, A., Jedlitschky, G., Schrör, K., & Rauch, B. H. (2015) · Mediators of Inflammation · doi:10.1155/2015/831059 · Cited by 67
Müller, J. U., von Bernstorff, W., Heidecke, C.-D., & Schulze, T. (2017) · BioMed Research International · doi:10.1155/2017/7584621 · Cited by 74
Olivera, A., & Rivera, J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9533-9_8 · Cited by 68
Self-citationClinical pharmacology, efficacy, and safety aspects of sphingosine-1-phosphate receptor modulators
Juif, P., Kraehenbuehl, S., & Dingemanse, J. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1196188 · Cited by 62
“The S1P receptor family is involved in homeostatic responses and regulates a wide range of physiological and pathophysiological processes of the cardiovascular, pulmonary (Figure 1(b)), immune (Figure 1(c)), and nervous (Figure 1(d)) systems [1,13,14].”
BackgroundLee, S. H., Lee, S.-Y., Lee, Y.-S., Kim, B.-J., Lim, K.-H., Cho, E.-H., Kim, S.-W., Koh, J.-M., & Kim, G. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1044 · Cited by 60
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity
Montrose, D. C., Scherl, E. J., Bosworth, B. P., Zhou, X. K., Jung, B., Dannenberg, A. J., & Hla, T. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034108 · Cited by 60
Walsh, K. B., Teijaro, J. R., Rosen, H., & Oldstone, M. B. A. (2011) · Immunologic Research · doi:10.1007/s12026-011-8240-z · Cited by 62
The Role of Sphingosine-1-Phosphate in Breast Cancer Tumor-Induced Lymphangiogenesis
Aoyagi, T., Nagahashi, M., Yamada, A., & Takabe, K. (2012) · Lymphatic Research and Biology · doi:10.1089/lrb.2012.0010 · Cited by 59
“Increased S1P production has been implicated in various physiological and pathological processes such as cancer, atherosclerosis, allergy, and autoimmune diseases such as multiple sclerosis.(13,16,17) S1P exerts its functions either by binding to its specific receptor in autocrine, paracrine, and/or endocrine manner a…”
BackgroundSphingosine kinase 1 in viral infections
Carr, J. M., Mahalingam, S., Bonder, C. S., & Pitson, S. M. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.1718 · Cited by 61
Barnawi, J., Tran, H. B., Jersmann, H. P. A., Pitson, S. M., Roscioli, E., Hodge, G. L., Meech, R., Haberberger, R. V., & Hodge, S. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122771 · Cited by 61
“Interestingly, in our previous study the relative mRNA for S1PR5 was significantly lower in whole lung tissue of patients with COPD compared to controls without COPD [16].”
BackgroundInfluentialMechanical forces induce an asthma gene signature in healthy airway epithelial cells
Kılıç, A., Ameli, A., Park, J., Kho, A. T., Tantisira, K. G., Santolini, M., Cheng, F., Mitchel, J. A., McGill, M., O’Sullivan, M. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57755-8 · Cited by 65
Takuwa, N., Du, W., Kaneko, E., Okamoto, Y., Yoshioka, K., & Takuwa, Y. (2011) · Europe PMC (PubMed Central) · Cited by 78
Donovan, E. E., Pelanda, R., & Torres, R. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939858 · Cited by 60
Selective recruitment of non-classical monocytes promotes skeletal muscle repair
Emeterio, C. L. S., Olingy, C. E., Chu, Y., & Botchwey, E. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.021 · Cited by 64
“Monocyte recruitment following the onset of injury is crucial for repair, as multiple studies have shown that depletion of circulating monocytes before toxin-induced muscle injury results in incompletely healed, fibrotic muscle [24].”
Cavone, L., Felici, R., Lapucci, A., Buonvicino, D., Pratesi, S., Muzzi, M., Hakiki, B., Maggi, L., Peruzzi, B., Caporale, R., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.019 · Cited by 64
“These receptors, in particular S1P1, are essential for lymphocytes to sense S1P, which represents a key signal to promote T cell egress from secondary lymphoid organs (Rivera et al., 2008; Pham et al., 2010).”
BackgroundSekar, D., Hahn, C., Brüne, B., Roberts, E., & Weigert, A. (2012) · European Journal of Immunology · doi:10.1002/eji.201142093 · Cited by 66
“S1P is a potent lipid mediator that signals via specific G protein coupled receptors to control aspects of phagocyte biology [40].”
BackgroundSaba, J. D., & Degagné, É. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43453 · Cited by 68
CD69: An Unexpected Regulator of T H 17 Cell–Driven Inflammatory Responses
Martı́n, P., & Sánchez‐Madrid, F. (2011) · Science Signaling · doi:10.1126/scisignal.2001825 · Cited by 59
“The absence of CD69 is associated with increased abundance of S1P 1 and, therefore, with enhanced migration of T lymphocytes to lymph nodes or infl amed tissues (28).”
BackgroundKulinski, J. M., Muñoz‐Cano, R., & Olivera, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.058 · Cited by 61
“These lipid-binding receptors modulate host defense and the allergic immune response, among other biological processes, by affecting vascular permeability and contractility, chemotaxis of immune cells to sites of inflammation and by inducing varied responses in stromal cells (Boyce, 2007; Honda et al., 2002; Rivera et…”
BackgroundInfluentialSelf-citationSphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration
Zhang, J., Dunk, C., & Lye, S. J. (2013) · Human Reproduction · doi:10.1093/humrep/det339 · Cited by 58
Inducible IL-33 Expression by Mast Cells Is Regulated by a Calcium-Dependent Pathway
Hsu, C., & Bryce, P. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201224 · Cited by 61
“S1P generated downstream of Sphk activation has been shown to be released by mast cells and act via S1P receptors expressed on the surface of mast cells in an autocrine manner to further increase calcium signaling (39).”
BackgroundSukocheva, O. A., Lukina, E., McGowan, E. M., & Bishayee, A. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.11.003 · Cited by 64
Sphingolipids and atherosclerosis
Hornemann, T., & Worgall, T. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.041 · Cited by 63
“S1P mediates pleiotropic effects by engaging S1PRs that affect immune cell migration, vascular integrity and inflammation [41,79].”
BackgroundOertel, S., Scholich, K., Weigert, A., Thomas, D., Schmetzer, J., Trautmann, S., Wegner, M.-S., Radeke, H. H., Filmann, N., Brüne, B., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2518-9 · Cited by 61
“Sphingolipids are essential for physiological properties of cell membranes and play a distinct role as second messengers in signaling pathways [10, 11].”
BackgroundThe molecular pathways underlying host resistance and tolerance to pathogens
Glass, E. J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00263 · Cited by 64
“The authors measured weight loss and pathogen burden following infection and identified a genetic locus on mouse chromosome 11 (Ctrq3), which influenced pathogen load i.e., resistance as well as weight loss and thus suggest that the same locus controls resistance and tolerance.”
BackgroundMacrophage phagocytosis cracking the defect code in COPD
Jubrail, J., Kurian, N., & Niedergang, F. (2017) · Biomedical Journal · doi:10.1016/j.bj.2017.09.004 · Cited by 64
“The mode of action of thymoquinone is unknown but data suggests it modulates the sphingosine 1 phosphate signalling system, which is critical for various macrophage functions [74].”
BackgroundPLP‐dependent enzymes as entry and exit gates of sphingolipid metabolism
Bourquin, F., Capitani, G., & Grütter, M. G. (2011) · Protein Science · doi:10.1002/pro.679 · Cited by 63
Daum, G., Grabski, A. D., & Reidy, M. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.175240 · Cited by 54
Phillips-Farfán, B. V., Carvajal, K., Alejandro, M.-T. E., Elva, E.-P. S., Fabriàs, G., & Camacho, L. (2016) · Mediators of Inflammation · doi:10.1155/2016/9890141 · Cited by 63
“Once produced, Cer and related lipids participate in inflammatory processes of several tissues, where they stimulate immune cells [13–15] by triggering their mitogen-activated protein kinase (MAPK) pathway [16].”
BackgroundChanging the threshold—Signals and mechanisms of mast cell priming
Hálová, I., Rönnberg, E., Dráberová, L., Vliagoftis, H., Nilsson, G. P., & Dráber, P. (2018) · Immunological Reviews · doi:10.1111/imr.12625 · Cited by 56
The signaling lipid sphingosine 1-phosphate regulates mechanical pain
Hill, R. Z., Hoffman, B. U., Morita, T., Campos, S. M., Lumpkin, E. A., Brem, R. B., & Bautista, D. M. (2018) · eLife · doi:10.7554/elife.33285 · Cited by 53
Sassoli, C., Pierucci, F., Zecchi‐Orlandini, S., & Meacci, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225545 · Cited by 57
Al‐Jarallah, A., Chen, X., González, L., & Trigatti, B. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106487 · Cited by 64
“S1P is known to be a modulator of immune cell migration and appears to mediate the migration of endothelial cells treated with HDL [52,58,59].”
BackgroundSphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells
Sharma, N., Akhade, A. S., & Qadri, A. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712328 · Cited by 52
the CHARGE Consortium Hematology Working Group (2016) · Nature Genetics · doi:10.1038/ng.3607 · Cited by 52
Self-citationDendritic cell sphingosine-1-phosphate lyase regulates thymic egress
Zamora-Pineda, J. B., Kumar, A., Suh, J. H., Zhang, M., & Saba, J. D. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160287 · Cited by 58
“S1P levels are highest in plasma and lowest in the lymphoid organs (Rivera et al., 2008).”
BackgroundFingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
Thomas, K., Proschmann, U., & Ziemssen, T. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1373093 · Cited by 52
“Besides S1PR1, fingolimod-phosphate also activates S1PR3, S1PR4 and S1PR5 additionally expressed on antigen-presenting cells (APC), monocytes or natural-killer (NK) cells (Figure 1) [13,25].”
BackgroundWu, J., Ma, S., Sandhoff, R., Ming, Y., Hotz‐Wagenblatt, A., Timmerman, V., Bonello‐Palot, N., Schlotter‐Weigel, B., Auer‐Grumbach, M., Seeman, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.005 · Cited by 55
“For example, sphingosine 1-phosphate (S1P) regulates T cell trafficking and modulates differentiation of regulatory T (Treg) cells and T helper 1 (Th1) cells (Kappos et al., 2010; Liu et al., 2009; Liu et al., 2010; Matloubian et al., 2004; Rivera et al., 2008).”
BackgroundFat for fuel: lipid metabolism in haematopoiesis
Pernes, G., Flynn, M., Lancaster, G. I., & Murphy, A. J. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1098 · Cited by 56
“This study also demonstrates that previous exposure to S1P inhibits HSPC mobilisation when re-exposed to S1P which could be explained through two mechanisms: (1) the receptor S1PR1 is downregulated when exposed to high concentrations of S1P in circulation, and (2) S1P binds to S1PR2, another S1P receptor with chemotac…”
BackgroundCurrent understanding of Th2 cell differentiation and function
Li, Z., Zhang, Y., & Sun, B. (2011) · Protein & Cell · doi:10.1007/s13238-011-1083-5 · Cited by 66
“Recent studies indicate that the emigration of Tcells from thymus and secondary lymphoid organs is also regulated by S1P receptors (Schwab and Cyster, 2007; Rivera et al., 2008).”
BackgroundDendritic cell altered states: what role for calcium?
Salter, R. D., & Watkins, S. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00806.x · Cited by 56
“The product sphingosine-1-phosphate (S1P) induces release of Ca from the ER independently of IP3 and also diffuses from cells and can bind to S1P receptors on the plasma membrane (28, 29).”
BackgroundRole of the Sphingosine Rheostat in the Regulation of Cnidarian-Dinoflagellate Symbioses
Detournay, O., & Weis, V. M. (2011) · Biological Bulletin · doi:10.1086/bblv221n3p261 · Cited by 51
“Identification of differentially expressed SPPase in symbiotic anemones led us to hypothesize that sphingolipids are involved in the regulation of cnidarian-dinoflagellate symbioses (Rodriguez-Lanetty et al., 2006).”
BackgroundDiscovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist
Nishi, T., Miyazaki, S., Takemoto, T., Suzuki, K., Iio, Y., Nakajima, K., Ohnuki, T., Kawase, Y., Nara, F., Inaba, S., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100301k · Cited by 51
Huu, D. L., Matsushita, T., Jin, G., Hamaguchi, Y., Hasegawa, M., Takehara, K., & Fujimoto, M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37933 · Cited by 51
“S1P1 plays important roles in migration, development, and differentiation of T cells and B cells (29).”
Annexin 2 Regulates Endothelial Morphogenesis by Controlling AKT Activation and Junctional Integrity
Su, S., Maxwell, S. A., & Bayless, K. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157271 · Cited by 51
Jojima, K., Edagawa, M., Sawai, M., Ohno, Y., & Kihara, A. (2020) · The FASEB Journal · doi:10.1096/fj.201902645r · Cited by 54
Bencardino, S., D’Amico, F., Faggiani, I., Bernardi, F., Allocca, M., Furfaro, F., Parigi, T. L., Zilli, A., Fiorino, G., Peyrin‐Biroulet, L., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155014 · Cited by 55
“Most immune cells produce S1P, which is essential for lymphocyte homing to lymphoid organs and migration of lymphocytes from secondary lymphoid organs, thymus, and bone marrow into the blood [20].”
BackgroundSuh, J. H., & Saba, J. D. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.10.06 · Cited by 52
“In addition to its role in the adaptive immune response, S1P signaling has been shown to contribute to innate immune functions including mast cell functions, monocyte and macrophage activity, T-reg functions, and cytokine signaling (68).”
BackgroundMcQuiston, T., Luberto, C., & Del Poeta, M. (2011) · Microbiology · doi:10.1099/mic.0.045989-0 · Cited by 49
“S1P1 is universally expressed on immune cells and is well established to govern the chemotaxic effects of extracellular S1P (Rivera et al., 2008).”
BackgroundInfluentialMuse Cells Are Endogenous Reparative Stem Cells
Kushida, Y., Wakao, S., & Dezawa, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56847-6_3 · Cited by 50
Chi, X. X., & Nicol, G. D. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00709.2010 · Cited by 48
Allende, M. L., Sipe, L. M., Tuymetova, G., Wilson-Henjum, K. L., Chen, W., & Proia, R. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478420 · Cited by 52
Self-citation
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.